Kelyniam's CEO Addresses Shareholders

   Kelyniam Global, Inc. (PINKSHEETS: KLYG) announces today that the company's CEO, Mr. James Ketner, has recently given an update on the company's current status to the shareholders. The following are excerpts from the Shareholder update.

"In the month of February alone we have made the most significant advancements in accomplishing our pursuit of entering the medical discipline. There are still a few more hurdles to overcome in this arena but we are confident that these obstacles will be resolved in the next couple months, hopefully sooner. We have purchase orders in place with some big hospitals, and are currently scheduled for operations utilizing Kelyniam's Custom Cranial Implants. If these first operations are successful, then we are entering a market with some very large competitors.

Our current capacity to manufacture any type of implant is about 1,500 units per year, and with our current pricing, we are estimating about 4.5 million in revenues if we reach full capacity. We can double that capacity in about two months if necessary, so there is really not any limitation on what we can produce. We have the latest state of the art equipment to meet these needs, and the talent to operate this equipment.

We recently teamed up with the sales force at Synergy Surgical. The guys at Synergy are young and aggressive and will be diligently promoting our implant products. They work on the weekend, holidays, whatever it takes to get the job done, and that to me is impressive. We do the same over here at Kelyniam, doesn't matter if it is Saturday, Sunday, holiday, if something needs to be done, we are here to tackle the problem or meet schedule.

We are currently investigating moving our engineering manufacturing facility in Connecticut and combining the corporate office with the engineering division to increase efficiency and to reduce operating cost. I am currently in favor of moving this to the city of Little Rock. The other consideration is moving both the corporate and the engineering division to the North Carolina research triangle in the Raleigh-Durham and Chapel Hill area. The decision will be made on the most favorable options the State of Arkansas will offer and the State of North Carolina.

Last year, we regretfully lost the employ of Ms. Michelle LynRay and have not found a replacement for her role. After several attempts at her replacement, we are still pursuing the accountant position vacancy. She was a huge asset to the company and her constant professionalism and diligence along with her friendship and perspective will be greatly missed.

Kelyniam is not pursing the MRI centers since the director that was going to handle that project has left the company. Kelyniam has not, or will not be raising money for the MRI centers by selling stock in the open market or by selling to private investors.

Again, these are some things that would be important to me if I were considering investing in a small startup company like ours. There are some great risks involved with investing in our company stock, and these risks should be considered before doing so."

James Ketner President/CEO

The entire letter can be found by going to the company website and selecting the link investor relations, or by following this link, www.kelyniam.com/investor_relations.asp

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact: James Ketner President/CEO Kelyniam Global, Inc. www.kelyniam.com 1-800-280-8192